S. Kannan et al., COEXPRESSION OF RAS P21 AND EPIDERMAL GROWTH-FACTOR RECEPTOR DURING VARIOUS STAGES OF TUMOR PROGRESSION IN ORAL MUCOSE, Tumor biology, 15(2), 1994, pp. 73-81
Ras p21 and epidermal growth factor receptor (EGFR) have commonly been
implicated in a variety of malignancies. The present study immunohist
ochemically analysed the relationship between the expression of ras p2
1 and EGFR in normal, premalignant and malignant lesions of the oral m
ucosa. Except for normal mucosa, all other lesions showed a more or le
ss similar expression pattern of both ras p21 and EGFR. It was also ob
served that the expression of both proteins was mostly confined to the
basal or basaloid cells of the leucoplakia and carcinoma lesions, res
pectively. Normal keratinizing type mucosa showed expression of ras p2
1 and EGFR in the basal and lower spinal cells. However, in non-kerati
nizing mucosa the expression of ras p21 was totally negative while EGF
R was restricted to the basal cells. Statistical analysis revealed a g
ood correlation between the expression of ras p21 and EGFR with the va
rious histological stages of tumour progression. The presence of these
proteins in immature dividing cells of premalignant and malignant les
ions thus emphasizes their relationship with cell proliferation.